To prepare patients for the risks of anesthesia and surgery through education. To encourage patients to ask well informed questions prior to surgery and anesthesia.

Malignant Hyperthermia in Anesthesia

Malignant Hyperthermia as a Killer

In the early years of modern anesthesia, a rare but deadly condition was identified resulting in a severe rise in temperature, pulse rate and blood pressure.  These patients also developed a profound muscular rigidity, renal failure, and death.  This was, fortunately, a very rare circumstance occurring once in 10,000 to one in 50,000 cases.  It became known as Malignant Hyperthermia.  

Treatment and Prevention Today

Since that time we have learned a great deal about this disorder.  Fortunately, we now have an antidote drug called dantrolene available since the 1970’s.  It is now possible to treat this condition before it is a significant problem.  In the case of a new onset of Malignant Hyperthermia and this drug is made available theoretically the mortality should be close to zero.

HIPAA Associates HIPAA Associates